NewAmsterdam Pharma Company N.V. ( NAMS) - Stock Earnings
NAMS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
NAMS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -74.9 million USD | 32000 USD |
| 2026Q1 | -48.4 million USD | 3.0 million USD |
| 2026Q2 | -64.1 million USD | 3.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NAMS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -176.9 million USD | 14.1 million USD |
| 2024 | -241.6 million USD | 45.6 million USD |
| 2025 | -203.8 million USD | 22.5 million USD |
| 2026 Est. | — | — |
NAMS
Price: $20.62
52 week price:
Earnings Per Share: -2.16 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.6 billion